อายุรศาสตร์ จุฬาลงกรณ์ Chulalongkorn Internal Medicine

Cumedicine Board => CU Medicine Public Board => Topic started by: dissaruj on March 04, 2018, 02:51:33 PM

Title: ID conference on Tuesday March 6, 2018
Post by: dissaruj on March 04, 2018, 02:51:33 PM

Journal session : Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies
Fellow : Worawong C.

9.00 – 10.00 a.m.
I.D. Conference Room, 5th floor, Bhumisiri mangkhalanusorn building
For more, please visit http://www.idchula.org/
______________________________________________

Dissaruj Tovikkai,MD
นพ.ดิษรุจ โตวิกกัย